As per DelveInsight’s assessment, the Clinical Diagnostics Market is expected to grow at an immense pace in the coming years owing to the The increasing prevalence of pandemic such as COVID-19, Pre- and post-operation and some few of the other applications where Clinical Diagnostics have been used, which is expected to drive the demand for Clinical Diagnostics in the upcoming years.
DelveInsight’s “Clinical Diagnostics Market” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Clinical Diagnostics companies actively working in the market.
Clinical Diagnostics Overview
Clinical diagnostics is the process of using a physical examination or laboratory test to determine the cause of an illness or condition based on the patient’s signs and symptoms. Numerous tests, including lipid panel testing, blood tests, and cancer screenings, are among those that may be part of clinical diagnostics.
Clinical Diagnostics Market Insights
The increasing prevalence of different chronic conditions, including cancer, blood disorders, and liver disorders, among others, is one of the main causes driving the demand for clinical diagnostics. The global clinical diagnostic market is anticipated to be supported during the forecast period of 2023–2028 by a number of factors, including growing strategic business activities for the establishment of new clinical diagnostic labs globally, a rise in the adoption of point-of-care clinical diagnostic tests, and growing technological advancement in the product portfolio.
DelveInsight Analysis: The Global Clinical Diagnostics market size was valued ~USD 70 billion by 2022 and expected to grow with a CAGR of 7.02% during the forecasted period (2023-2028).
To know more about why North America is leading the market growth in the Clinical Diagnostics market, get a snapshot of the report Clinical Diagnostics Market Trends
https://www.delveinsight.com/report-store/clinical-diagnostics-market
Recent Developments in the Clinical Diagnostics Market Report
- On July 26, 2021, Leading provider of clinical diagnostics worldwide Beckman Coulter signed formal agreements with Quidel Corporation to acquire full rights to produce, market, and sell a BNP test for Beckman Coulter analyzers. As per the agreements, Quidel will keep producing and supplying specific assay-related components to Beckman Coulter, and Beckman Coulter will be the only company producing and offering for sale the BNP assay that Quidel is presently selling as TRIAGE® BNP under the Access BNP brand.
- On April 13, 2021, One of the biggest in-vitro diagnostics firms in the world, Ortho Clinical Diagnostics, obtained CE Marking for their VITROS® SARS-CoV-2 Antigen Test.
- On November 19, 2020, Authorization to market or import the Platelia SARS-CoV-2 Total Ab test for COVID-19 testing in Canada was given to Bio-Rad.
To read more about the latest highlights related to Clinical Diagnostics, get a snapshot of the key highlights entailed in the Clinical Diagnostics Market Forecast Report
Key Players in the Clinical Diagnostics Market
Some of the key market players operating in the Clinical Diagnostics market include- Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, Siemens AG, Hologic, Inc., Qiagen NV, Quest Diagnostics Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Sysmex, Sonic Healthcare Ltd, Exact Sciences Corporation, NeoGenomics, Inc., BioReference Laboratories, Laboratory Corporation of America® Holdings, DiaSorin, PerkinElmer Inc., FUJIFILM Corporation, and others.
COVID-19 Impact Analysis on the Clinical Diagnostics Market
In 2022, North America is anticipated to have a dominant position in the worldwide clinical diagnostics market, a trend that is anticipated to continue from 2023 to 2028. The region’s growing incidence of chronic blood diseases such infectious diseases, chronic illnesses like cancer, deficient disorders, and others is to blame for this dominance in income creation. The factors driving the growth of the US clinical diagnostic market furthermore include an increase in government initiatives in the region, an increase in product approvals, and a growing emphasis on R&D activities by the major manufacturers.
Additionally, The rise in infectious diseases, including bacterial, fungal, and viral illnesses like COVID-19, is also anticipated to increase demand for clinical diagnosis globally, driving up market share throughout the projected period. So, during the projected period, the market for Clinical Diagnostics is anticipated to continue expanding (2023-2028).
Scope of the Clinical Diagnostics Market Report
- Coverage: Global
- Study Period: 2020–2028
- Clinical Diagnostics Market Segmentation By Type: Products [Instruments, Kits & Reagents], Services
- Clinical Diagnostics Market Segmentation By Test: Complete Blood Count (CBC), Metabolic Panel, Lipid Panel, Renal Panel, Liver Panel, Infectious Disease Testing, and Others
- Clinical Diagnostics Market Segmentation By End User: Hospitals, Pathology Labs, and Others
- Clinical Diagnostics Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
- Key Clinical Diagnostics Companies: Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, Siemens AG, Hologic, Inc., Qiagen NV, Quest Diagnostics Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Sysmex, Sonic Healthcare Ltd, Exact Sciences Corporation, NeoGenomics, Inc., BioReference Laboratories, Laboratory Corporation of America® Holdings, DiaSorin, PerkinElmer Inc., FUJIFILM Corporation, and others
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the Clinical Diagnostics market are set to emerge as the trendsetter explore @ Clinical Diagnostics Manufacturer
Table of Contents
|
1 |
Clinical Diagnostics Market Report Introduction |
|
2 |
Clinical Diagnostics Market Executive summary |
|
3 |
Regulatory and Patent Analysis |
|
4 |
Clinical Diagnostics Market Key Factors Analysis |
|
5 |
Porter’s Five Forces Analysis |
|
6 |
COVID-19 Impact Analysis on Clinical Diagnostics Market |
|
7 |
Clinical Diagnostics Market Layout |
|
8 |
Global Company Share Analysis – Key 3-5 Companies |
|
9 |
Company and Product Profiles |
|
10 |
Clinical Diagnostics Market Drivers |
|
11. |
Clinical Diagnostics Market Barriers |
|
12. |
Project Approach |
|
13. |
About DelveInsight |
Interested in knowing how the Clinical Diagnostics market will grow by 2028? Click to get a snapshot of the Clinical Diagnostics Market Analysis
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email: Send Email
Phone: 8774225362
Address:27 Drydock Ave S. Jones Blvd #2432
City: Boston
State: MA
Country: United States
Website: https://www.delveinsight.com/consulting/asset-prioritizaton-services